Patents by Inventor Himanshu Patel
Himanshu Patel has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20250103322Abstract: Various embodiments include systems and methods for updating firmware on a computing device. A computing device may determine essential image sections and non-essential image sections of a working firmware image stored in a flash memory of the computing device. The computing device may store the data in the non-essential image sections on a host device as a backup image, erase the data in the non-essential image sections from the flash memory, receive an update firmware image from the host device, store essential image sections of the update firmware image to the flash memory, and reboot the computing device from the essential image sections of the update firmware image stored in the flash memory.Type: ApplicationFiled: September 21, 2023Publication date: March 27, 2025Inventors: Himanshu SRIVASTAVA, Suhaskumar PATEL
-
Publication number: 20250082840Abstract: A smart charging station may be capable of accessing data from an ambulatory medicament device at particular times, such as when the ambulatory medicament device is charging or connected to the charging station. The smart charging station may then communicate the data to another electronic system, such as a remote system. Advantageously, the charging station enables an ambulatory medicament device that may not be capable of communicating with a remote system to transfer ambulatory medicament device data to the remote system. Further, the remote system may communicate with the ambulatory medicament device via the charging station enabling, for example, control parameter updates, software updates, or permission modifications, among other communications with the ambulatory medicament device regardless of whether direct communication with the ambulatory medicament device is possible.Type: ApplicationFiled: December 27, 2022Publication date: March 13, 2025Applicant: Beta Bionics, Inc.Inventors: Himanshu Patel, Michael J. Rosinko, Firas H. Khatib
-
Patent number: 12204889Abstract: Systems and methods relate to an ambulatory medicament device that can generate a dose control signal to cause a medicament pump to infuse medicament into a subject. The system can analyze status to determine whether an alarm condition for the ambulatory medicament device or for a subject is already present in a list of pending alarm conditions. If the alarm is not present, the system can determine a severity level of the alarm condition from among a plurality of severity levels and annunciate the alarm condition using one or more annunciation patterns selected based on the severity level of the alarm condition for the medicament device or for the subject. The system may maintain an indication of the alarm condition on the list of pending alarm conditions until the alarm condition is resolved.Type: GrantFiled: September 27, 2021Date of Patent: January 21, 2025Assignee: Beta Bionics, Inc.Inventors: Michael J. Rosinko, David Chi-Wai Lim, Edward R. Damiano, Firas H. El-Khatib, Himanshu Patel, Justin P. Brown, Bryan Dale Knodel
-
Patent number: 12093681Abstract: An ambulatory medicament device can generate a dose control signal for delivery of medicament to a subject and secure at least some functionality of a user interface of the ambulatory medicament device. The ambulatory medicament device can have a locked state that restricts modification of at least one control parameter. The ambulatory medicament device can have an unlocked state that allows modification of at least one control parameter. The ambulatory medicament device can accept a user input of a security code that is validated against a passcode to enter from the locked state to the unlocked state.Type: GrantFiled: September 27, 2021Date of Patent: September 17, 2024Assignee: Beta Bionics, Inc.Inventors: Michael J. Rosinko, Himanshu Patel, Edward R. Damiano, Firas H. El-Khatib
-
Publication number: 20240256267Abstract: An ambulatory medical device can detect a device condition and determine if the device condition satisfies a set of normal operating parameters. If the normal operating parameters are not satisfied, the ambulatory medical device can determine if the device condition stratifies a set of minimum operating parameters. If the minimum operating parameters are satisfied, the ambulatory medical device can maintain a delivery of therapy to a subject and generate an alert based on the device condition.Type: ApplicationFiled: February 14, 2024Publication date: August 1, 2024Applicant: Beta Bionics, Inc.Inventors: Michael J. Rosinko, Himanshu Patel, Edward R. Damiano, Firas H. EI-Khatib, David Chi-Wai Lim
-
Publication number: 20240173475Abstract: Ambulatory medicament devices that provide therapy to a subject, such as blood glucose control, are disclosed. Disclosed systems and methods can implement one or more features that improve the user experience, by modifying delivery of therapy to a subject after determining that a possible occlusion exists in a medicament delivery system, monitoring the status of an ambulatory medical device and the health condition of a subject that receives therapy from the ambulatory medical device and annunciating alarm condition when necessary, selectively muting alarm annunciations while a Do Not Disturb mode is activated, implementing various power saving modes to save power, controlling operation of the device and medicament delivery based on the user gesture controls, and controlling medicament delivery based on a condition of the ambulatory medicament device.Type: ApplicationFiled: February 2, 2024Publication date: May 30, 2024Applicant: Beta Bionics, Inc.Inventors: Michael J. Rosinko, Firas H. El-Khatib, Himanshu Patel
-
Patent number: 11941392Abstract: An ambulatory medical device can detect a device condition and determine if the device condition satisfies a set of normal operating parameters. If the normal operating parameters are not satisfied, the ambulatory medical device can determine if the device condition stratifies a set of minimum operating parameters. If the minimum operating parameters are satisfied, the ambulatory medical device can maintain a delivery of therapy to a subject and generate an alert based on the device condition.Type: GrantFiled: September 27, 2021Date of Patent: March 26, 2024Inventors: Michael J. Rosinko, Himanshu Patel, Edward R. Damiano, Firas H. El-Khatib, David Chi-Wai Lim
-
Patent number: 11925788Abstract: Ambulatory medicament devices that provide therapy to a subject, such as blood glucose control, are disclosed. Disclosed systems and methods can implement one or more features that improve the user experience, by modifying delivery of therapy to a subject after determining that a possible occlusion exists in a medicament delivery system, monitoring the status of an ambulatory medical device and the health condition of a subject that receives therapy from the ambulatory medical device and annunciating alarm condition when necessary, selectively muting alarm annunciations while a Do Not Disturb mode is activated, implementing various power saving modes to save power, controlling operation of the device and medicament delivery based on the user gesture controls, and controlling medicament delivery based on a condition of the ambulatory medicament device.Type: GrantFiled: March 2, 2022Date of Patent: March 12, 2024Assignee: Beta Bionics, Inc.Inventors: Michael J. Rosinko, Firas H. El-Khatib, Himanshu Patel
-
Publication number: 20240062867Abstract: Ambulatory medicament devices that provide therapy to a subject, such as blood glucose control, are disclosed. Disclosed systems and methods can implement one or more features that improve the user experience, by modifying delivery of therapy to a subject after determining that a possible occlusion exists in a medicament delivery system, monitoring the status of an ambulatory medical device and the health condition of a subject that receives therapy from the ambulatory medical device and annunciating alarm condition when necessary, selectively muting alarm annunciations while a Do Not Disturb mode is activated, implementing various power saving modes to save power, controlling operation of the device and medicament delivery based on the user gesture controls, and controlling medicament delivery based on a condition of the ambulatory medicament device.Type: ApplicationFiled: December 17, 2021Publication date: February 22, 2024Applicant: Beta Bionics, Inc.Inventors: David Chi-Wai Lim, Firas El-Khatib, Himanshu Patel, Michael Rosinko, David Henderson, Justin Brown
-
Publication number: 20240056830Abstract: The present disclosure provides a system and method for facilitating tracking area code (TAC) engine to prepare dynamic network polygons based on actual configuration, allocation of TAC to new cell sites, identification of various discrepancies and anomalies in existing planned network, capacity optimization through TAC Division, merge and network polygon edit, and auto work order generation and execution of changes in respective systems, MME Pool and eNB/SCs. Tracking Area Code is a vital parameter for new sites planning and rollout. The method complements network rollout speed with highest level of accuracy of planning and better network perform nave and accuracy. Auto planning engine makes TAC planning zero touch engine with manual review and action through manual edit, audit and work order creation features. Auto planning and configuration help faster rollout, speedy correction and implementation in live network to enhance network performance and user experience.Type: ApplicationFiled: May 31, 2022Publication date: February 15, 2024Inventors: Aayush BHATNAGAR, Haresh AMBALIYA, Vikram SINGH, Himanshu PATEL, Manish PATEL, Arunima SARKAR
-
Publication number: 20240024578Abstract: A glucose level control system may be configured to determine that certain status information fails to satisfy at least one of a plurality of safety thresholds. The system may receive status information, which may include device information pertaining to a condition of the ambulatory medicament device and/or subject information pertaining to a condition of a subject. The system can determine that the status information fails to satisfy the safety threshold(s). In response to determining that the status information fails to satisfy the at least one of a plurality of safety thresholds, the system can automatically execute a distress action. Example safety thresholds include a glucose level of a subject being less than a minimum threshold, a glucose level of a subject being greater than a maximum threshold, a movement of the subject being less than a minimum movement threshold for a threshold amount of time, and/or other safety thresholds.Type: ApplicationFiled: July 18, 2023Publication date: January 25, 2024Inventors: Himanshu Patel, Michael J. Rosinko, Firasd H. El-Khatib, Edward R. Damiano
-
Publication number: 20230405224Abstract: A glucose level control system may be configured to determine a recommended medicament dose based at least in part on a subject's therapy data and/or user-specified medicament related inputs. The therapy data may include glucose level data and medicament delivery data. The user-specified medicament related inputs may include qualitative meal announcements. For example, the user can specify that the subject consumed a small, medium, or large meal. The glucose level control system may be configured to output an indication of the recommended medicament dose to a display. The glucose level control system may be configured to output a dose control signal to preconfigure a smart pen to deliver the recommended medicament dose. The glucose level control system may be configured to generate an alert if it determines, based at least in part on glucose level data and/or medicament delivery data associated with the subject, that trigger criteria have been satisfied.Type: ApplicationFiled: April 6, 2023Publication date: December 21, 2023Inventors: Michael J. Rosinko, Himanshu Patel, Firas H. El-Khatib
-
Patent number: 11803367Abstract: Systems and methods are disclosed herein for monitoring the status of an ambulatory medical device and the health condition of a subject that receives therapy from the ambulatory medical device. The ambulatory medical device can have a touchscreen display user interface to receive input signals from a user and display alarm conditions associated with the status of an ambulatory medical device or health condition of a subject. The disclosed methods and systems can determine whether status information received from a monitoring system interface satisfies an alarm condition for the ambulatory medicament device or for the subject. If the status information satisfies an alarm condition, the touchscreen user interface can display one or more alarm status indicators corresponding to the alarm condition. The user can activate a therapy change interface on the touchscreen display and modify a control parameter of the ambulatory medical device that controls the therapy delivery to the subject.Type: GrantFiled: September 27, 2021Date of Patent: October 31, 2023Assignee: Beta Bionics, Inc.Inventors: Michael J. Rosinko, Edward R. Damiano, David Chi-Wai Lim, Firas H. El-Khatib, Justin P. Brown, Bryan Dale Knodel, Himanshu Patel
-
Publication number: 20230338643Abstract: A glucose level control system can intermittently receive alarm data corresponding to instances where an alarm was triggered and receive a request for the remote support system to contact the user. The system can transmit the request to the remote support system and determine that at least one of a plurality of support system criteria are satisfied. The control system can automatically identify a category of concern related to the request and generate a report of usage based on the category of concern and on the alarm data. The control system may transmit the report of usage to a remote electronic device and determine a support resource configured to receive the report of usage associated with the glucose level control system. The control system can generate a connection alert that is configured to request contact with a support request interface operatively coupled to the ambulatory medicament pump.Type: ApplicationFiled: April 18, 2023Publication date: October 26, 2023Inventors: Michael J. Rosinko, Himanshu Patel, Edward R. Damiano, Firas H. El-Khatib
-
Publication number: 20230337949Abstract: A glucose level control system may be configured to determine that certain status information fails to satisfy at least one of a plurality of safety thresholds. The system may receive status information, which may include device information pertaining to a condition of the ambulatory medicament device and/or subject information pertaining to a condition of a subject. The system can determine that the status information fails to satisfy the safety threshold(s). In response to determining that the status information fails to satisfy the at least one of a plurality of safety thresholds, the system can automatically execute a distress action. Example safety thresholds include a glucose level of a subject being less than a minimum threshold, a glucose level of a subject being greater than a maximum threshold, a movement of the subject being less than a minimum movement threshold for a threshold amount of time, and/or other safety thresholds.Type: ApplicationFiled: April 19, 2023Publication date: October 26, 2023Inventors: Michael J. Rosinko, Himanshu Patel, Edward R. Damiano, Firas H. El-Khatib
-
Patent number: 11776374Abstract: The present invention provides an improved electronic fall monitoring system comprising a device having multiple sensor ports for flexibly monitoring various sensors associated with a single patient without requiring repeated connections and disconnections of sensors. With several sensors simultaneously connected at different locations, a processor can execute to ensure that only one sensor, corresponding to one patient, is monitored at any given time, including by triggering an alarm when a second sensor is triggered while a first sensor is in use. Accordingly, the system can provide a “one step transfer” in which a caregiver may simply press hold once to transfer a patient from one sensed area to another. In addition, the caregiver can simply actuate a single input with only a momentary press to allow suspension of monitoring for a shorter duration (hold) or a longer press to allow suspension of monitoring for a longer duration (extended hold).Type: GrantFiled: December 13, 2021Date of Patent: October 3, 2023Assignee: TIDI Products, LLCInventors: Roy Seizo Carr, Glen Holt Humphrey, Drew Deem Coatney, Himanshu Patel, Lisa McHale, Brian N. Young, Justin K. Thomas
-
Patent number: 11768676Abstract: Systems and methods are disclosed herein for switching control of an ambulatory medical device from an application executing on the ambulatory medical device to a safe version or a new version of the application without interrupting therapy provided by the ambulatory medical device to a subject. The ambulatory medical device can maintain copies of a safe version and a new version of the application. The disclosed systems and methods can execute the new version, while the prior version of the application continues to execute, determine whether a minimum set of operating conditions are satisfied by the new version, and switch control of the ambulatory medical device from the prior version to the new version. The systems and methods can also automatically revert to the safe version of the application case the current version is malfunctioning without interrupting therapy provided to the subject.Type: GrantFiled: September 17, 2021Date of Patent: September 26, 2023Assignee: Beta Bionics, Inc.Inventors: Michael J. Rosinko, Edward R. Damiano, David Chi-Wai Lim, Firas H. El-Khatib, Himanshu Patel, John R. Costik, Justin P. Brown, Bryan Dale Knodel
-
Publication number: 20230298724Abstract: A medical device, such as an ambulatory medicament pump or associate control system, can receive a use state comprising user interactions with the glucose level control system. The device can determine that the use state satisfies at least one of a plurality of user interaction criteria. The plurality of user interaction criteria can include a variety of various interaction criteria. In response to determining that the use state satisfies the at least one of the plurality of user interaction criteria, the system can automatically generate the user alert comprising a link to training content. The link can direct a user to the training content in response to user interaction with the link.Type: ApplicationFiled: March 17, 2023Publication date: September 21, 2023Applicant: Beta Bionics, Inc.Inventors: Michael J. Rosinko, Himanshu Patel, Edward R. Damiano, Firas H. El-Khatib
-
Patent number: 11698785Abstract: Systems and methods are disclosed herein for switching an application executing on an ambulatory medical device to a new application without interrupting therapy provided by the ambulatory medical device to a subject. The ambulatory medical device may receive an indication that an update to an application executing on the ambulatory insulin pump is available, establish a communication connection to a host computing system, download and install the application update, while a prior version of the application continues to run. The disclosed systems and methods can confirm successful installation of the application update on the ambulatory medical device and switch control of the ambulatory medical device from the prior version to the new version of the application without interrupting therapy provided to the subject.Type: GrantFiled: September 17, 2021Date of Patent: July 11, 2023Assignee: Beta Bionics, Inc.Inventors: Himanshu Patel, Michael J. Rosinko, Edward R. Damiano, David Chi-Wai Lim, Firas H. El-Khatib, John R. Costik, Justin P. Brown, Bryan Dale Knodel
-
Publication number: 20230201659Abstract: A system and method for optimizing a patient's Kegel exercises is provided. The system includes a user interface device and a vaginal device. The vaginal device includes an intra-vaginal probe having an accelerometer that is configured to generate a signal in response to movement of the probe. The user interface device is connected to the vaginal device and analyzes signals from the accelerometer to provide physiological feedback information to the patient. The vaginal device may be connected to the user interface device via wireless communications such as Bluetooth or by wire. The user interface device may be a smart device or a computer that transmits information to central web-based data server accessible by the patient or authorized healthcare providers or third-party payers.Type: ApplicationFiled: August 29, 2022Publication date: June 29, 2023Inventors: Ramon Jose IGLESIAS, David J. MISHELEVICH, Sean C. NASH, Kaitlin B. SCHAEFER, Jahnavi LOKRE, Milan V. TRCKA, Himanshu PATEL, Jan B. ZWIERSTRA, Trevor DUNLOP, Aaron GIFFORD